Antibiotic use in dermatologic surgery

Dermatologic Clinics

Volumn 21, Issue 2, 2003, Pages 337-348

  Babcock, Melissa Dawn ^a   Grekin, Roy C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFOTETAN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DICLOXACILLIN; FLUCONAZOLE; KETOCONAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; HUMAN; OPERATION DURATION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN SURGERY; WOUND INFECTION;

EID: 0038747202     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00096-7     Document Type: Review

References (46)

1. Haas AF, Grekin RC. Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995;32:155-76.
2. Baran CN, Sensoz O, Ulusoy MG. Prophylactic antibiotics in plastic and reconstructive surgery. Plast Reconstr Surg 1999;103:1561-6.
3. Barreca M, Stipa F, Cardi E, et al. [Antibiotic prophylaxis in the surgical treatment of inguinal hernia: need or habit?]. Minerva Chir 2000;55:599-605 [in Italian].
4. Dobay KJ, Freier DT, Albear P. The absent role of prophylactic antibiotics in low-risk patients undergoing laparoscopic cholecystectomy. Am Surg 1999;65:226-8.
5. Gupta R, Sinnett D, Carpenter R, et al. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur J Surg Oncol 2000;26:363-6.
6. Gaspar Z, Vincuillo C, Elliott T. Antibiotic prophylaxis for full-face laser resurfacing: is it necessary? Arch Dermatol 2001;137:313-5.
7. Manuskiatti W, Fitzpatrick RE, Goldman MP, et al. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999;40:77-84.
8. 2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999;25:857-61.
9. Friberg D, Lundberg C. Antibiotic prophylaxis in major head and neck surgery when clean-contaminated wounds are established. Scand J Infect Dis Suppl 1990;70:87-90.
10. Weber RS, Callender DL. Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol Suppl 1992;155:16-20.
11. DiPiro JT, Record KE, Schanzenbach KS, et al. Antimicrobial prophylaxis in surgery: part 1. Am J Hosp Pharm 1981;38:320-4.
12. Johnson JT, Myers EN, Thearle PB, et al. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984;94:46-51.
13. Rodrigo JP, Alvarez JC, Gomez JR, et al. Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck 1997;19:188-93.
14. Righi M, Manfredi R, Farneti G, et al. Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery. Head Neck 1996;18:399-404.
15. Mustafa E, Tahsin A. Cefotaxime prophylaxis in major non-contaminated head and neck surgery: oneday vs. seven-day therapy. J Laryngol Otol 1993;107:30-2.
16. Monaco G, Staffolani C, Gatto MR, et al. Antibiotic therapy in impacted third molar surgery. Eur J Oral Sci 1999;107:437-41.
17. Higgins A, London J, Charland S, et al. Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary? Arch Surg 1999;134:611-3.
18. Johnson JT, Wagner RL. Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg 1987;113:368-9.
19. Klimberg IW, Malek GH, Cox CE, et al. Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery. J Antimicrob Chemother 1999;43(Suppl A):77-84.
20. Makris N, Iatrakis G, Sakellaropoulos G, et al. The role of antibiotics after dilatation and curettage in women with metrorrhagia in the prevention of pelvic inflammatory disease. Clin Exp Obstet Gynecol 2000;27:27-8.
21. Bizer LS, Ramos S, Weiss PR. A prospective randomized double blind study of perioperative antibiotic use in the grafting of ulcers of the lower extremity. Surg Gynecol Obstet 1992;175:113-4.
22. Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol 1989;20:367-90.
23. Bruce S. Antibacterial agents. In: Wolverton SE, editor. Systemic drugs for skin disease. Philadelphia (PA): WB Saunders; 1991. p. 47-85.
24. Sadick NS. Systemic antibacterial agents. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. Philadelphia (PA): WB Saunders; 2001. p. 28.
25. Lazzarini L, Pellizzer G, Stecca C, et al. Postoperative infections following total knee replacement: an epidemiological study. J Chemother 2001;13:182-7.
26. Lilienfeld DE, Vlahov D, Tenney JH, et al. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control 1988;16:3-6.
27. Tabet JC, Johnson JT. Wound infection in head and neck surgery: prophylaxis, etiology and management. J Otolaryngol 1990;19:197-200.
28. Simchen E, Shapiro M, Marin G, et al. Risk factors for post-operative wound infection in cardiac surgery patients. Infect Control 1983;4:215-20.
29. Noman TA, Raja'a YA, Assiraji HM, et al. Rate of wound infection after clean surgery. Saudi Med J 2001;22:58-60.
30. Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg 1973;107:206-10.
31. Valentine RJ, Weigelt JA, Dryer D, et al. Effect of remote infections on clean wound infection rates. Am J Infect Control 1986;14:64-7.
32. Sebben JE. Sterile technique and the prevention of wound infection in office surgery - Part I. J Dermatol Surg Oncol 1988;14:1364-71.
33. Nichols RL. Surgical wound infection. Am J Med 1991;91:54S-64S.
34. Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis. A review. Medicine (Baltimore) 1977;56:61-77.
35. Jeserich M, Just H. [Current status of endocarditis prevention]. Z Kardiol 2001;90:385-93 [in German].
36. Taubert KA, Dajani AS. Optimisation of the prevention and treatment of bacterial endocarditis. Drugs Aging 2001;18:415-24.
37. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997;25:1448-58.
38. Park JY. Prevention of bacterial endocarditis: American Heart Association recommendations. JAMA 1997;278:1232; discussion 1233.
39. Little JW. Patients with prosthetic joints: are they at risk when receiving invasive dental procedures? Spec Care Dentist 1997;17:153-60.
40. McGowan DA, Hendrey ML. Is antibiotic prophylaxis required for dental patients with joint replacements? Br Dent J 1985;158:336-8.
41. Jacobson JJ, Millard HD, Plezia R, et al. Dental treatment and late prosthetic joint infections. Oral Surg Oral Med Oral Pathol 1986;61:413-7.
42. Fitzgerald Jr RH. Infections of hip prostheses and artificial joints. Infect Dis Clin N Am 1989;3:329-38.
43. Sanderson PJ. The choice between prophylactic agents for orthopaedic surgery. J Hosp Infect 1988;11(Suppl C):57-67.
44. Segreti J, Levin S. The role of prophylactic antibiotics in the prevention of prosthetic device infections. Infect Dis Clin N Am 1989;3:357-70.
45. Ainscow DA, Denham RA. The risk of haematogenous infection in total joint replacements. J Bone Joint Surg Br 1984;66:580-2.
46. Anonymous. Advisory statement. Antibiotic prophylaxis for dental patients with total joint replacements. American Dental Association: American Academy of Orthopaedic Surgeons. J Am Dent Assoc 1997;128:1004-8.